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X-ray-based virtual slicing of
tB-infected lungs
Ana ortega-Gil1,2,3, Juan José Vaquero  1,2, Mario Gonzalez-Arjona2, Joaquín Rullas3 & 
Arrate Muñoz-Barrutia  1,2*
Hollow organs such as the lungs pose a considerable challenge for post-mortem imaging in preclinical 
research owing to their extremely low contrast and high structural complexity. the aim of our study was 
to enhance the contrast of tuberculosis lesions for their stratification by 3D x-ray–based virtual slicing. 
Organ samples were taken from five control and five tuberculosis-infected mice. Micro-Computed 
tomography (ct) scans of the subjects were acquired in vivo (without contrast agent) and post-mortem 
(with contrast agent). the proposed contrast-enhancing technique consists of x-ray contrast agent 
uptake (silver nitrate and iodine) by immersion. To create the histology ground-truth, the CT scan of 
the paraffin block guided the sectioning towards specific planes of interest. The digitalized histological 
slides reveal the presence, extent, and appearance of the contrast agents in lung structures and 
organized aggregates of immune cells. These findings correlate with the contrast-enhanced micro-CT 
slice. the abnormal densities in the lungs due to tuberculosis disease are concentrated in the right tail 
of the lung intensity histograms. The increase in the width of the right tail (~376%) indicates a contrast 
enhancement of the details of the abnormal densities. Postmortem contrast agents enhance the x-ray 
attenuation in tuberculosis lesions to allow 3D visualization by polychromatic x-ray CT, providing 
an advantageous tool for virtual slicing of whole lungs. the proposed contrast-enhancing technique 
combined with computational methods and the diverse micro-ct modalities will open the doors to the 
stratification of lesion types associated with infectious diseases.
Cutting-edge translational research on preclinical models of infectious lung diseases rely on computed tomog-
raphy (CT) images for the assessment of infection burden and in particular, for the evaluation of new effective 
antibiotic combinations for tuberculosis (TB) treatment1,2.
The stratification of abnormal x-ray densities associated with tuberculosis is highly challenging in preclinical 
research owing to low lung contrast and the ground glass appearance of lesions. Contrast agents enhance the x-ray 
attenuation of soft-tissue and could allow 3D visualization of lesion composition when using a polychromatic 
x-ray CT scan3–5. The hypothesis driving this work was that the enhancement of complex lung structures by
conventional contrast agents would allow the stratification of tuberculosis lesions by post mortem polychromatic 
x-ray imaging.
The use of contrast agents with a high atomic number (most commonly iodine or barium) for micro-CT
imaging is extensively reported in the literature both for in vivo and postmortem studies3,6,7. Small iodinated 
agents are commonly injected into blood vessels to enable visualization of the vascular system and organ perfu-
sion8 or for the estimation of the volumetric air, blood, and tissue fractions in the rodent lung when imaging with 
dual-energy scans9. Barium contrast medium is typically administered orally or with an enema to investigate the 
anatomy of the gastrointestinal tract8. For lung lesions, the number of options to perform longitudinal follow-up 
of the disease decreases notably. In the case of lung cancer models, iopamidol lipid, iodinated lipid, and inor-
ganic nanoparticulate agents enable differentiation between the intensities of tumours, vascular structures, and 
thoracic air space and thus, identification of tumour margins and accurate quantification10. Postmortem studies 
also benefit from the use of contrast agents, as micro-CT imaging of excised organs (e.g., heart, lung, brain)11,12 
and even whole animals (e.g., chick embryos)11 allow for 3D non-destructive virtual histology examination. This 
circumvents the challenges inherent to performing 3D histological reconstruction of the whole organ from serial 
sections, which is a difficult and laborious procedure.
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Common criteria to characterize lesions histologically rely on organization: ‘organized’ lesions are bounded 
by a peripheral cuff of lymphocytes13–15. Several models accurately reflect aspects of the progression of disease in 
macaques, marmosets16–23, zebrafishes24,25, and mice13–15. In this work, we chose a resistant murine model whose 
host-pathogen dynamics present in non-necrotic lesion and predominantly intracellular bacilli. The lesions pres-
ent in our murine model are ‘unorganized’ and typically small. The cellular composition consists of two layers: a 
peripheral rim of foamy macrophages and a central cup of neutrophil focus26,27 (Fig. 1).
The aim of our study was to enhance tuberculosis lesions for 3D x-ray–based virtual slicing. The proposed 
contrast-enhancing technique consists of high-atomic number contrast agent uptake by immersion. Aware of the 
limitations and resolution differences with classical histology, we will use the term x-ray based virtual slicing to 
refer to the 3D section visualization with enough resolution to identify lung structures in whole organs already 
prepared for classical histological analysis. The resolution of the x-ray based virtual slicing is determined by the 
imaging platform (44um, in our case). To illustrate that the enhancement can be achieved with multiple contrast 
agents, we present two alternatives (silver nitrate and iodine) targeting the diagnostic x-ray energy range (10 keV, 
150 keV)9,28–30.The contrast-enhanced organs are embedded in ethanol and then moved to paraffin, which enables 
longer storage of the biological phantom at room temperature. The histological analysis of our samples reveals the 
distribution of the contrast agent in the lesion subtypes associated with the tuberculosis model under study and 
the nature of their abnormal x-ray density.
Materials and Methods
The sequential steps of the contrast-enhancing technique are presented in Fig. 2. The technique was based on 
excised whole organs from procedures ethically reviewed and carried out in accordance with European Directive 
2010/63/EEC and the GSK Policy on the Care, Welfare and Treatment of Animals. This experimental protocol 
entitled “Búsqueda de nuevos tratamientos frente a la tuberculosis”, with project number PROEX 63/14, was 
approved by the Consejería de Medio Ambiente de la Comunidad de Madrid. The mouse organs were excised 
from ten females of the C57BL/6 J strain. Five were inoculated with 100 CFUs of the virulent tuberculosis H37Rv 
strain at the age of 8−12 weeks. The Tuberculosis strain was originally disassociated by Steenken et al.31, and 
the infection protocol was optimized by our team. All animals were sacrificed eight weeks after the intratra-
cheal insult. At that time, the infected mice had reached the chronic phase of the disease. Before the lungs were 
extracted, 1.5 ml of 10% formalin were instilled through the trachea.
Inflated lung contrast-enhancement. The mouse organs were dehydrated by graded ethanol concentra-
tion fixation (GECF), a prior biochemical conditioning step described by de Silva et al.6. GECF begins with 50% 
ethanol for one hour and proceeds with ethanol solutions at increasing concentrations (70, 80, 90, 96 and 100%) 
for one hour each.
After fixation, eight of the ten samples were immersed in the contrast agent solution for 14 hours. Two 
dissected healthy mouse lungs and two dissected TB-infected mouse lungs were immersed in silver nitrate 
(Sigma-Aldrich Co.) in 3% w/v ethanol solution (saturated). Two dissected healthy mouse lungs and two dis-
sected TB-infected mouse lungs were immersed in iodine (Sigma-Aldrich Co.) in 3% w/v ethanol solution. The 
two remaining samples (one dissected healthy mouse lung and one dissected tuberculosis-infected mouse lung) 
were also prepared for histology without any contrast agent and served as controls.
Figure 1. High-magnification histological slide of a tuberculous lesion, eight weeks after the infection in a 
murine model of the disease. The image shows the rim of foamy macrophages and a neutrophil focus. The 
colour scale helps the identification of the cells based on the haematoxylin-eosin stain, which enhance the nuclei 
and adds contrast for the cytoplasm and extracellular matrix.
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To prevent abrupt shrinkage of the fixed sample and ensure homogeneous uptake throughout the subse-
quent immersions (GECF and contrast agent), the organs were kept in suspension at a constant pressure of 20 
cmH2O by connecting a computerized pneumatic circuit to the tracheal catheter. The pressure system keeps the 
lungs inflated in suspension to guarantee a homogeneous uptake, due to the subtle fluid stream. It also serves to 
prevent the lung tissue from collapsing, even in the case of perforation. The system design can be found in the 
Supplementary Appendix A (Supplementary Fig. 1).
Samples were stored in a 2 ml plastic container filled with 70% ethanol to prevent further dehydration of the tis-
sue. All the steps describing the contrast-enhancing protocol are summarized in the Supplementary Appendix B.
The whole organs were immersed in paraffin blocks to prepare for histological sectioning.
Micro-CT whole lung and histological sections imaging. A standard micro-CT subsystem of a 
SuperArgus scanner (Sedecal Molecular Imaging, Madrid) was used for both in vivo and excised lung scans. The 
selected acquisition protocol was the manufacturer’s protocol for soft-tissue imaging tasks, which follows the “as 
low as reasonably achievable” principle stated in the Code of Federal Regulations (10 CFR 20.1003). Acquisition 
parameters are detailed in Table 1. Datasets were reconstructed using the filtered back-projection algorithm32.
Before euthanizing the subjects, the ten mice were screened in vivo by micro-CT. These in vivo scans were 
acquired to confirm the infective stage and lesion location. The excised lungs were screened post-mortem two 
times: once the lungs uptook the contrast agent and were embedded in ethanol and once when embedded in 
paraffin (Fig. 2).
The axial 44-µm–thick CT slices of the paraffin blocks were acquired parallel to the microtome slicing plane, 
thus resulting in the aligned virtual volumes used to define the histology planes. Namely, planes of interest con-
taining relevant tuberculosis lesions were selected on the micro-CT volume and their depth in micrometres 
from the paraffin surface was estimated (Supplementary Fig. 2). Three histological sections were processed per 
mouse: the first, with no further staining other than the contrast agent; the second, with haematoxylin to enhance 
the nuclei; and the third, with haematoxylin-eosin, which adds the contrast for the cytoplasm and extracellular 
matrix. In total, 30 slides were digitalized using the Aperio CS2 image capture device (Leica Biosystems Nussloch 
GmbH, De) at 40x magnification and 0.251 µm × 0.251 µm pixel size.
tissue analysis in micro-ct scans. First, the volume preservation of the processed samples was assessed. 
The morphometric parameters applied for the assessment of sample preservation on the micro-CT scans were 
the total volume of the healthy lung and the volume of the diseased tissues in the infected samples. The tissues 
Figure 2. Flow chart for the contrast-enhancing technique: Inflated fixed lungs are immersed in the contrast 
agent solution. After 14 hours, they are stored in ethanol, and a micro-CT scan is performed. The organ is then 
embedded in paraffin and a second micro-CT scan is performed. Finally, after preparation with haematoxylin 
and haematoxylin-eosin, slices are digitized using optical microscopy. Micro-CT scans and histopathological 
images are ready for visual inspection and quantitative analysis.
Imaging task In vivo Excised lungs
Scan type Step and shoot
Tube voltage 68 kVp
Tube current 420 µA
Filtration 0.2 mm Cu + 1.8 mm Al intrinsic
Exposure time 50 ms
Circular projection 514 over 360°
Averaged projections 
per angular step 4 8
Magnification 3.3
Pixel size (pixel binning) 0.29 mm (4 × 4) 0.14 mm (2 × 2)
Data volume (per frame) 2.17 GB (1.44 MB) 4.27 GB (2.88 MB)
Total acquisition time 8 minutes 16 minutes
Voxel size 88 × 88 × 88 µm 44 × 44 × 44 µm
Table 1. Micro CT acquisition protocols and parameters for each imagining task. The scanner was optimized 
for soft-tissue imaging in both cases in terms of x-ray filtration and detection sensitivity.
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of interest were identified in the micro-CT slices based on the difference in their grey levels, enhanced by the 
contrast agent.
Lung volumes are quantified using thresholds computed from the histograms of lung voxels in Hounsfield 
units (HU), as described in Chen, R et al.33. In brief, intensity windows can be depicted to individually capture 
lung tissue or apparent disease from the micro-CT scans. The thresholds delimiting each window are established 
to divide the HU histogram of the virtual volumes into the three parts above mentioned (healthy lung tissue, rim 
of foamy macrophages and neutrophil foci). Sample volumes were calculated by summing the total volume of the 
voxels belonging to each window. For the volumetric estimations, an expert radiologist selected the thresholds 
defining healthy tissue and disease associated tissue by visual inspection of the in vivo and the ethanol-embedded 
micro-CT scans. The thresholds for the paraffin-embedded micro-CT scans were selected using the histopatho-
logical labelling information by registering the micro-CT slices with histological slides and statistically modelling 
the HU distribution, as described in our previous work in Ortega-Gil, A et al.34. This methodology translates his-
topathological segmentation to micro-CT segmentation and provides a satisfactory estimation of the granuloma 
cellular structure. (Supplementary Table 1).
In the case of the contrast agents used for x-ray imaging, we studied the effect on the attenuation factor of 
the tissues. For this quantitative evaluation of contrast enhancement in lung tissue, we provide the edge-based 
contrast criterion (ECC) as a local index.
The ECC is defined as the average of the pixel contrast values35,36 and is computed as follows:
ECC
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where G is the Sobel gradient magnitude.
tissue analysis in histology. Histology is the gold standard for morphological tissue assessment. The tis-
sue sections were analysed and labelled by three independent pathologists to evaluate the sample preservation 
after the preparation procedure in terms of obstructed/unobstructed airways and depiction of the lung cell types. 
Histology revealed the presence, extent, and appearance of the contrast agents in the tuberculosis lesions as indi-
cators of the contrast enhancement in the micro-CT scans.
Results
The micro-CT scans of the samples embedded in paraffin facilitate the selection of planes-of-interest for histo-
logical staining. Axial slices of the 3D micro-CT scans of the paraffin blocks and their corresponding histological 
slides are shown in Fig. 3 both for silver nitrate enhanced lungs (Fig. 3a infected; Fig. 3b healthy control) and 
iodine enhanced lungs (Fig. 3c infected; Fig. 3d healthy control). The contrast of the lungs with contrast agent is 
homogeneous as observed in the histological slides (Fig. 3, right panel). The dehydration step increases cell mem-
brane permeation, and the contrast-agent molecules diffuses more easily into the tissue6.
The air spaces are homogeneously inflated, the septal walls are thin, and the corner vessels are open in the 
histological sections shown in Fig. 3a–c, suggesting successful perfusion fixation. In contrast, the section of the 
thoracic pluck shown in Fig. 3d presents areas of alveolar wall collapse (blue arrow head) and high contrast agent 
precipitation on the heart tissue (H red letter). This indicates that the extraction and perfusion fixation are critical 
for tissue preservation. When any of these stages fails, the resulting samples (as the one shown) present partially 
collapsed regions that cannot be recovered by the pressure system.
The bronchiolar ducts are maintained in all the cases. The conductive airways are unobstructed, with the 
expected diameter for the bronchus divisions (~1 cm). The width of the alveolar walls also measures within the 
typical range reported by literature37. In Fig. 3a,b,d the oesophagus is visible in the centre of the sections (orange 
dashed circles). In the histological cuts of infected mice (Fig. 3c,d), we observe patchy areas of alveoli filled with 
inflammatory cells (L red letter). The destruction of lung tissue is also visible, along with diffuse oedema associ-
ated with the accumulation of a larger number of inflammatory cells.
The whole organ presents contrast-agent uptake. Higher pool concentrations and background padding are 
found proximal to the tuberculosis lesions.
To obtain a detailed view of the contrast agent deposition, we acquired high-resolution histology images of 
tissue borders (first row, Fig. 4) and tuberculosis lesions (second row, Fig. 4). All sections are stained with hae-
matoxylin (left column: no contrast agent; central column: silver contrast-agent; right column: iodine contrast 
agent). The lung cells remain intact both for healthy and diseased tissue. The lungs with silver nitrate are black, 
and the lungs with iodine are yellow on visual inspection. Neither of the contrast agents interferes with the his-
tological counterstain. The contrast agent presence is visible as scattered pools distributed extensively on every 
tissue (encircled in orange in Fig. 4), which corresponds with the overall attenuation increase of the whole organ 
in the x-ray based virtual slicing. The deposition on the edges is responsible for the intensity frontier between 
the embedding media and the organ in the micro-CT scan. Silver nitrate and iodine are ionic contrast agents 
that promote the precipitation of proteins and chlorides38,39. Thus, significantly higher pool concentrations and 
background padding are found proximal to clusters of cells, targeting the structures with the abnormal densities 
(i.e., tuberculosis lesions) identified in the corresponding micro-CT slices. While these findings are not specific 
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for tuberculous lesions, the trend towards adhering to highly populated regions is consistent with the contrast 
enhancement in the CT scans associated with inflammatory tuberculosis lesions which are already visible at week 
8 after inoculation37,40.
Figure 3. Micro-CT slices and their corresponding histology slide. Lung with silver nitrate uptake: (a) Infected; 
(b) Healthy. Lung with iodine uptake: (c) Infected; (d) Healthy. The airways are unobstructed (dashed orange 
circles), and the structure of the parenchyma has been preserved. Lesions (red L letter) are visible, with higher 
contrast uptake (higher intensities) at the central foci. High contrast agent precipitation is also present on the 
heart tissue (H red letter).Tissue preservation in (d) is reduced owing to complications during instillation at the 
isolation and fixation step, presenting collapsed alveolar walls (blue arrow head). The scale bar is common for all 
the thumbnails and measures 2 mm.
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The hollow tissue decreases in volume when embedded in ethanol and further decreases when embedded in 
paraffin. However, the volume of the lesion core remains consistent.
The volume preservation of the relevant tissues (i.e., healthy lung, disease associated (lesion peripheral rim 
and central foci)) of the infected contrast-enhanced samples was estimated from the in vivo micro-CT scans and 
from those acquired on the excised organs embedded in ethanol and in paraffin. Figure 5 shows a sample thumb-
nail of the histological slide of the paraffin block (a) registered with the micro-CT slice (b) and the correspond-
ing segmentation (c) for an infected lung with iodine uptake. Figure 5c is the automatic segmentation with the 
thresholds estimated from the HU histogram (d) and colour code: the organ is delimited with blue; in the lesions, 
the rim of macrophages is delimited in green and the neutrophil foci in red. The applied thresholds are specified 
in the HU histogram (d).
Our estimations show that the healthy lung tissue volume decreases slightly (14,3%) after the 
contrast-enhancing and embedding in ethanol, while the total diseased volume (including the peripheral rim and 
the central foci) decreases abruptly (53,7%). The former is due to the tissue dehydration and the latter is caused by 
the accurate delimitation of the peripheral rim edge enabled by the improved contrast. The hollow tissue (healthy 
parenchyma (31,8%), total diseased tissue (33,5%) and peripheral lesion rim (27,4%)) further decrease their vol-
ume after embedding in paraffin, as expected, while the lesion core formed by the infiltrated nuclei maintains 
its volume. For a graphical representation of the estimated volumes we refer the reader to Supplementary Fig. 3.
In the micro-CT scans of the contrast-enhanced samples, the largely increased width of the right tail of the 
intensity histograms and the corresponding growth of the edge contrast measure points to an effective contrast 
enhancement of the relevant lung structures and TB-related manifestations.
Both histological images and micro-CT images can differentially assess contrast agent uptake into normal 
parenchyma and into tuberculosis-infected lung sites in postmortem whole lungs. The increase in contrast of the 
postmortem micro-CT scans with contrast agents provides detailed images of the relevant lung structures (i.e., air-
ways, blood vessels, and abnormalities). Those structures are unidentifiable in the postmortem micro-CT images 
of the control samples which were not enhanced with either contrast agent (Supplementary Fig. 4). For that rea-
son, all subsequent metric comparisons refer to the in vivo micro-CT scans acquired before euthanizing the mice.
Figure 6 illustrates the contrast enhancement in the micro-CT images of the lung structures and tuberculosis 
lesions of the infected animals due to the contrast agent. Raw reconstructed tomographic volumes were used 
for analysis before any processing or re-slicing. Each histogram shows the probability distribution of the voxel 
greyscale values (linear scale [HU]) from the concatenation of the segmented lung volumes available per condi-
tion. The 3D reconstructions on the right are shown for illustrative purposes. From the histogram, the mean and 
Figure 4. Presence, extent, and appearance of the contrast agent deposition in tissue areas of the histology 
presenting abnormal density (i.e., blood vessel walls, airway walls, tuberculosis lesions) in the micro-CT images. 
All sections are stained with haematoxylin. Borders of the tissue (first row) and lesion regions (second row) 
are shown by columns for: No CA) no contrast agent, AgNO3) silver contrast agent, and I2) iodinated contrast 
agent. Orange circles indicate the pools of the contrast agents. A difference on the background colour is also 
noticeable. The scale bar represents 200 um.
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standard deviation values of a Gaussian fit of the intensity probability distribution were computed (Table 2). With 
respect to in vivo scans, the histograms of lungs with silver nitrate uptake are shifted by 771 HU (354 HU) when 
embedded in ethanol (paraffin); the histograms of lungs with iodine uptake are shifted by 663 HU (261 HU) in 
ethanol (paraffin). This may be due to the relatively large voxel sizes of micro-CT imaging and the consequent 
partial volume effect which mixes the target tissues with the embedding medias (paraffin or ethanol). From our 
observations, the embedding material gets to fill the interalveolar septum and a pixel of size of 44 µm integrates 
multiple capillaries of the interalveolar septum. Paraffin presents a higher attenuation factor (mu) than ethanol 
as reflected in different shifts of the HU on the attenuation histograms. The abnormalities associated with the 
disease have intensities concentrated in the right tail of the histograms. The width of the right tail is measured as 
the difference between the 95th percentile value and the mean (Table 2). The increase in the width of the right tail 
of the silver nitrate lungs (497.72% when embedded in ethanol and 322.41%, in paraffin) and of the iodine lungs 
(397.52% when embedded in ethanol and 198.61%, in paraffin) indicates that the contrast of the abnormal densi-
ties has improved. The differences between the embedding medias may be due to the partial volume effect and to 
the washing effect of the lungs being two hours submerged in hot paraffin before building the block.
Figure 5. Illustration of the automatic segmentation procedure for the micro-CT scan of an infected lung with 
iodine uptake. The sample thumbnail of the histological slide (a) is registered with the micro-CT slice (b). The 
corresponding segmentation (c) was acquired by statistically modelling the HU distribution and translating the 
histopathological segmentation to micro-CT segmentation. The estimation of the thresholds of the granuloma 
cellular structure is shown by the grey level histogram. (d) The colour code for the intensity differences 
correspond with the lesion composition: the healthy parenchyma is in blue, the rim composed by foamy 
macrophages in green and the neutrophil foci in red.
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Figure 6. Quantitative measure of contrast estimated from the histogram of the micro-CT lung volumes. 
The histograms show the probability distribution of the voxel greyscale values (linear scale [HU]) from the 
concatenation of the segmented lung volumes available per condition. The axis legends are defined in the 
last graph and are the same for the three of them. A break in the y-axis is included from 16 to 28%. Renders 
of the micro-CT lung volumes from which the histograms have been computed are also shown The framing 
colour lines represent the legend of the graphs. Micro-CT scans of: (a) Lungs acquired in vivo (blue-dashed) 
and excised lungs without contrast agents (red); (b) Excised lungs with silver nitrate uptake acquired while 
embedded in ethanol (blue-dashed) and in paraffin (red); (c) Excised lungs with iodine uptake acquired while 
embedded in ethanol (blue-dashed) and in paraffin (red).
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Finally, the Edge Contrast Criterion (ECC) is computed on the four infected samples. For each embedding 
and each contrast agent, we considered the mean of the measurements for 31 slices per micro-CT volume of a 
lung region of interest with size 3.6 × 5.5 mm2. The ECC metric reveals contrast enhancement at relevant lung 
structures (Table 2).
Discussion
We have demonstrated that the contrast-agents are able to increase the attenuation of the lung lesions caused by 
tuberculosis in x-ray based virtual slicing. The acquisition of postmortem whole lungs allow the 3D assessment 
of the characteristics of abnormal bronchoalveolar tissue. We showed that this approach is not limited to a single 
contrast agent by presenting comparable results with silver nitrate and iodine solutions. In addition, we demon-
strated that our contrast-enhancing technique is compatible with disinfection protocols to inactivate pathogenic 
bacteria and allows subsequent analysis using classical histology. Our protocol does not introduce any additional 
shrinkage of the tissue other than that expected from the chemical drying procedure and paraffin embedding 
typical of standard histological examinations.
Regarding the imaging platform, we found that the advantage of micro-CT over 3D high-resolution micros-
copy imaging techniques is that the organs do not have to undergo the clearing process step required with single 
plane illumination microscopy41. Additionally, using micro-CT imaging for 3D virtual slicing avoids the com-
plexity of working with 2D serial sectioning that requires the application of stereology to estimate alveolar vol-
umes31 or the building of 3D reconstructions to perform histological analysis of the whole organ. As we also 
intend to use the contrast-agents in in vivo imaging and to achieve comparable results in vivo and postmortem, the 
micro-CT scan is the appropriate platform as it has enough resolution to visualize lung structures and large fields 
of view to fit murine models42.
It must also be considered that there is not an exact correspondence between the histology image and a slice 
in the micro-CT. The voxel size of our 2D micro-CT slice is 44 um, meaning that the image is a flat cross-section 
which integrates all the structures within 44 um depth, whereas the width of the histology samples is 3 um. At 
the time of the experiment, the optimal trade-off between computational burden and resolution was reached at 
the voxel resolution of 44 um, which gave the best virtual slices resolution-wise. Aiming to achieve virtual histol-
ogy in future studies, we will increase the computational capacity of our working station in order to achieve the 
required resolution for the excised stained lungs without binning.
The limitations intrinsic to the imaging platform available for this research, could also be overcome by alter-
native CT systems. Phase-contrast or dual-energy CT can increase the contrast-to-noise ratio for samples without 
contrast agent. However, these techniques are usually only feasible with synchrotron light sources43–48, which 
are only available in 73 facilities worldwide, thus preventing their use in high-throughput studies. Cutting-edge 
spectral systems are expected to demonstrate superior image quality, even with larger voxel sizes than standard 
CT systems, provided that the attenuation of subjects under study is enhanced30,49, which could be achieved by 
contrast-enhancing preparations such as the one we proposed.
The extent of the contrast-agent in the pulmonary tissue suggested that the radiological enhancement by 
Iodine and Silver is non-specific for tuberculosis lesions. Thus, this technique could be applied to any organ with 
the pathological manifestations of infectious diseases. The proposed contrast-agents tend to adhere to highly cell 
populated regions. Both contrast agents demonstrate low protein binding, thus explaining the clear depiction 
of vessels, airways, connective tissue, and lesions. The uptake of silver nitrate by soft-tissue samples is suscep-
tible of pitfalls and artefacts, mainly due to the sensitivity of the salt towards oxidation and the formation of a 
layer of metallic silver on the surface of the sample38. The accumulation of metallic silver on the sample surface 
and the dark colour of the lungs suggested that the immersion in the contrast agent was too long and excessive 
background formed. Reducing the time of the contrast-agent immersion to remove excess silver ion and other 
chemicals prior to further processing is required.
Due to the need for contrast-enhanced samples for material decomposition techniques, we chose to use a 
silver-based contrast agent for lung enhancement, since silver has a low absorption edge value that is detecta-
ble with any spectral scan. Silver-based contrast agents also presented higher contrast in conventional CT, thus 
facilitating the depiction of the rim and central regions of the lesions. The major advantage that encouraged 
us to develop this technique for iodine was its widespread use in in vivo imaging. Thus, our post-mortem seg-
mentation of the lesions enhanced with iodine can be translated to in vivo scans using the injectable form of the 
contrast-agent.
Embedding Histogram Gaussian fit (HU) Right tail width (HU) ECC increase (%)
In vivo μ = −481, σ = 134 394.9 —
Excised not enhanced μ = 56, σ = 241 711.2 —
Excised with silver nitrate uptake in ethanol μ = −127, σ = 252 1965.5 71.8
in paraffin μ = 290, σ = 391 1273.2 33.1
Excised with iodine uptake in ethanol µ = −222, σ = 155 1569.8 62.85
in paraffin µ = 182, σ = 323 784.3 25.66
Table 2. Metrics for the quantitative evaluation of contrast enhancement in lung tissue. Gaussian fit of the 
intensity histograms, width of the right tail of the histograms and the increase in edge contrast (ECC) of the 
micro-CT lung volumes available per condition (see Fig. 6).
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Many laboratories are actively working toward the development of contrast-enhancing techniques to use in 
combination with micro-CT for animal organs imaging6,11,50. Preparation techniques for murine organs try to 
avoid tissue collapse and enhance radiodensity by vascular perfusion with fixatives6,51 or formaldehyde inflation50. 
Our contribution in this line is the innovative computerized pneumatic circuit which overcomes the challenges of 
homogeneous uptake and tissue preservation even in the case of perforation.
The use of an automatic tissue processor that performs fixation, dehydration, and wax immersion treatment is 
widely applied in pathology laboratories. The contrast-enhancing step could be added to the cycle; however, the 
samples would be caged in the cassette, thus preventing the contrast agent from penetrating all lobes uniformly.
Comparison of lung volumes throughout the process shows the expected shrinkage reported in the litera-
ture50,52,53, with no additional shrinkage due to the contrast agents applied. We recommended that samples are 
stored in 70% ethanol to avoid further volume changes. An alternative to be considered is immersion in agarose 
gels, which do not wash out the contrast agent or dehydrate the sample11. In the case of paraffin storage, preserva-
tion can be assured and moreover, the lungs can be scanned with only a slight decrease in the image contrast while 
continuing to allow planning of the histological cuts to the regions of interest.
Silver nitrate produced higher contrast at a 3% concentration (saturated) than iodine at the same concentra-
tion on the analysed micro-CT images. A higher contrast could be achieved for iodine by increasing its concen-
tration up to its saturation limit. Subsequent histopathology enabled us to perform a detailed CT examination 
of the lung anatomy and composition from the payload carried by the contrast materials54. Consequently, in 
the future, this method may enable stratification of abnormal CT densities (including ground-glass opacities) 
associated with a wide variety of pulmonary diseases in preclinical research. Any other model of injury, infection 
or tumorigenesis which also present clusters of cells as hallmarks of the host response could be enhanced by 
high-atomic-number contrast agents in micro-CT imaging.
Potential adverse structural or health effects of contrast media have been extensively studied over the last 20 
years. As a result, the design of small-molecule image contrast agents has been highly optimized with successful 
examples such as lipid emulsions (Exitron 12000, Miltenyi Biotec) and nanoparticles (Mvivo Au, MediLumine). 
The physical, chemical, and pharmacological properties of contrast agents can be manipulated and modified to fit 
the desired application and its design specifications8.
In conclusion, the results obtained through our contrast-enhancement technique allows the discrimination of 
micrometre length complex lung structures for the stratification of tuberculosis lesions in mice samples. Probably 
the biggest advantage of this technique is the fast data acquisition and the non-destructive virtual slicing. Our 
method provides volumetric images by conventional preclinical CT scan, which is an imaging technique acces-
sible to the general scientific community. We challenge previous procedures in overcoming the ground glass 
opacities of the pathological condition of our samples by diffusing the contrast agent into the Tuberculosis lesions. 
While here our technique has been demonstrated with post mortem imaging, it provides the basis for designing a 
low-osmolar contrast agent/saline that could be used for in vivo imaging of the lung.
Data availability
The datasets used and/or analysed during the current study are available from the corresponding author on 
reasonable request.
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